Respiratory drug delivery
View
Understanding the biopharmaceutical barriers to the delivery and disposition of drugs in the airways underpins a number of research projects, including small drug molecules, peptides and biological therapeutics.
Inhaled drug delivery can be used to maximise delivery of the active ingredient to the site of action for local effects in the lungs or to the alveolar region of the lung for systemic absorption. The team have expertise in particle engineering to modulate the aerodynamic properties of particles to influence deposition in the airways.
Quality of Medicines Initiative
View
Professor McIntosh collaborates with Associate Professor (Practice) Pete Lambert in bringing world-class pharmaceutical science expertise to address issues of medicines' quality in resource-constrained settings through the Quality of Medicines Initiative.
Medicines Manufacturing Innovation Centre
View
Professor McIntosh is the Director of MMIC, which was founded in 2017 to provide advanced preclinical support to Australian health and medtech companies and to provide training for the future workforce in this expanding sector.